Department of Surgery, Division of Transplantation, University of Illinois at Chicago, 840 South Wood Street, Clinical Sciences Building, Suite 503, Chicago, IL 60612, USA.
Department of Surgery, Division of Transplantation, University of Illinois at Chicago, 840 South Wood Street, Clinical Sciences Building, Suite 520, Chicago, IL 60612, USA.
Gastroenterol Clin North Am. 2018 Jun;47(2):443-448. doi: 10.1016/j.gtc.2018.01.010. Epub 2018 Apr 4.
Obesity is considered a relative contraindication to pancreas transplantation due to an overall increased risk in wound-related complications and surgical site infections. The rationale for performing pancreas transplantation in a minimally invasive fashion is to reduce these risks, which can be associated with inferior patient and graft survival following pancreas transplantation in morbidly obese patients. At the University of Illinois at Chicago, the initial series of robotic-assisted pancreas transplantation in obese patient with type 1 and 2 diabetes has been performed. In this article, surgical technique and world experience in robotic pancreas transplantation are described.
肥胖被认为是胰腺移植的相对禁忌症，因为与伤口相关的并发症和手术部位感染的总体风险增加。以微创方式进行胰腺移植的基本原理是降低这些风险，这可能与病态肥胖患者胰腺移植后患者和移植物存活率降低有关。在伊利诺伊大学芝加哥分校，已经对 1 型和 2 型糖尿病肥胖患者进行了机器人辅助胰腺移植的初步系列手术。本文介绍了机器人胰腺移植的手术技术和世界经验。
